Clinical Trial 55407

Winter Park, FL 32789


Summary:

A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib.


Qualified Participants Must:

• 18 to 55 years of age
• Diagnosis of RMS


Qualified Participants May Receive:

Compensation for time and travel. 

Study-related care at no cost. 


Available At:

Conquest Research
2233 Lee Rd #101
Winter Park, FL 32789
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.